Welcome to our dedicated page for Petmed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express stock.
PetMed Express, Inc. (NASDAQ: PETS), widely recognized as PetMeds, is America's largest pet pharmacy. Established in 1996, PetMeds provides both prescription and non-prescription pet medications, health products, and nutritional supplements for dogs, cats, and horses directly to consumers at substantial savings. The company operates from a single location, delivering exceptional value and convenience to millions of satisfied customers nationwide.
PetMeds generates revenue primarily by selling pet medications and supplies, targeting retail consumers. The company prides itself on being a trusted pet health expert, offering competitive prices and convenient access to a wide range of products. Pet parents can purchase these products through PetMeds' toll-free number (1-800-PetMeds) or online at www.petmeds.com.
Recently, PetMeds partnered with Hill's Pet Nutrition to offer Hill's Science Diet products on PetMeds' platform starting March 1, 2024. To celebrate this partnership, PetMeds launched a promotional giveaway, providing a year's worth of Hill's Science Diet to one lucky winner. This initiative aligns with PetMeds' commitment to responsible pet ownership and support for animal shelters facing capacity crises.
PetMeds also offers innovative services like Pumpkin® pet insurance plans and same-day VetLive® telehealth appointments, making veterinary care more accessible and affordable. Furthermore, through its wholly-owned subsidiary, PetCareRx, PetMeds extends its reach by providing additional pet health products and services.
The company's financial stability is underscored by its consistent performance and strategic partnerships. PetMeds is scheduled to host a conference call on February 8, 2024, to discuss its third-quarter results, followed by a Q&A session. This event provides an opportunity for investors and stakeholders to gain insights into the company's operations and future plans.
For more information, visit www.petmeds.com or contact PetMeds' investor relations team at investor@petmeds.com.
PetMed Express (PETS) reported Q1 FY 2022 results with net sales of $79.3 million, down from $96.2 million a year ago. Net income was $4.4 million ($0.22/share), a decline from $7.8 million ($0.39/share) a year earlier. One-time charges totaled $717,000 due to the CEO's separation. Increased veterinary visits during the pandemic impacted sales, but future reorder sales are expected to be stronger. The company holds over $111 million in cash with no debt and declared a quarterly dividend of $0.30 per share, payable August 13, 2021.
PetMed Express (NASDAQ: PETS) will announce its financial results for the quarter ended June 30, 2021, on July 26, 2021, at 8:00 A.M. Eastern Time.
A conference call to discuss the results will follow at 8:30 A.M. ET, and is accessible to the public by dialing (888) 455-1758 or (203) 827-7025. A replay of the call will be available from July 26 at 10:00 A.M. until August 9, 2021.
Founded in 1996, PetMed Express delivers prescription and non-prescription medications for pets directly to consumers.
PetMed Express reported strong fiscal 2021 results, showing an 8.8% increase in net sales to $309.2 million and a 18.4% increase in net income to $30.6 million. Despite fourth-quarter challenges, with a 3.5% decrease in net sales to $71.7 million, the overall year reflected a successful pivot to e-commerce driven by COVID-19. The company acquired 443,000 new customers and improved average order size. An increased quarterly dividend of $0.30 per share was declared, reflecting ongoing confidence in future growth.
PetMed Express (PETS) will announce its financial results for the fiscal year ending March 31, 2021, on May 3, 2021, at 8:00 A.M. ET. CEO Menderes Akdag will host a conference call at 8:30 A.M. ET to discuss the results. The call is accessible to the public by dialing (888) 455-1758 or (203) 827-7025. A replay of the call will be available until May 17, 2021. Founded in 1996, PetMed Express is a leading pet pharmacy in the U.S. offering medications and health products for pets through its toll-free number and website.
PetMed Express, Inc. (NASDAQ: PETS) reported a 10% increase in quarterly net sales, reaching $65.9 million for the quarter ended December 31, 2020, compared to $59.9 million in the same quarter of 2019. Diluted EPS rose to $0.38 from $0.34. Year-to-date sales were $237.5 million, up 13.2%. Reorder sales climbed 11.9% to $60.2 million for the quarter. A quarterly dividend of $0.28 per share was declared, payable on February 12, 2021. The company continues to focus on enhancing customer experience and expanding its digital offerings.
PetMed Express will release its Q3 financial results for the period ending December 31, 2020, on January 19, 2021, at 8:00 A.M. Eastern Time. Following this, CEO Menderes Akdag will host a conference call at 8:30 A.M. Eastern Time to discuss the results. Participants can join the call by dialing (888) 455-1758 or (203) 827-7025 and must provide the passcode PETMEDS. For those unable to attend live, a replay will be available until February 2, 2021.
PetMed Express reported a strong performance for Q2 2020 with net sales reaching $75.4 million, up 7.9% from $69.9 million in Q2 2019. The net income rose 26.2% to $8.4 million or $0.42 per diluted share. Reorder sales also saw a significant increase of 9.6% to $67.8 million. With gross margins improving from 27.8% to 30.5%, the company is set to enhance its digital presence by redesigning its website and mobile app. A quarterly dividend of $0.28 per share was declared, payable on November 20, 2020.
PetMed Express (NASDAQ: PETS) is scheduled to announce its financial results for Q2 2020 on October 26, 2020, at 8:00 A.M. ET. CEO Menderes Akdag will host a conference call at 8:30 A.M. ET to discuss these results. The call is public and can be accessed at (888) 455-1758 with the passcode PETMEDS. A replay will be available from 10:00 A.M. ET on the same day until November 9, 2020. PetMed Express is recognized as America’s Largest and Most Trusted Pet Pharmacy, providing prescription and non-prescription pet medications directly to consumers.
PetMed Express (NASDAQ: PETS) reported a 20% increase in net sales for the first quarter ended June 30, 2020, totaling $96.2 million, up from $80.0 million in the same period last year. Net income rose 47% to $7.8 million, or $0.39 diluted per share. New order sales grew 29% to $15.8 million, while reorder sales increased 19% to $80.4 million. The company acquired 186,000 new customers, enhancing its average order size to $89. A quarterly dividend of $0.28 per share has been declared, payable on August 7, 2020.
PetMed Express (NASDAQ: PETS) will report its financial results for Q1 2020 on July 20, 2020, at 8:00 A.M. ET. A conference call led by CEO Menderes Akdag will follow at 8:30 A.M. ET, accessible via phone at (888) 455-1758 or (203) 827-7025 with passcode PETMEDS. For those unable to attend live, a replay will be available from 10:00 A.M. ET on the same day until August 3, 2020.
Founded in 1996, PetMed Express is a leading online pet pharmacy, providing a range of medications and health products for pets.
FAQ
What is the current stock price of Petmed Express (PETS)?
What is the market cap of Petmed Express (PETS)?
What does PetMed Express, Inc. do?
Where can I buy PetMeds products?
What recent partnerships has PetMeds announced?
What is the significance of PetMeds’ partnership with Hill's Pet Nutrition?
Does PetMeds offer pet insurance?
What other services does PetMeds provide?
Who are PetMeds' primary customers?
When is PetMeds' next conference call?
How can I contact PetMeds for investor relations?
What is PetCareRx?
